Cost-Effectiveness Analysis of GDMT Uptitration After Acute Decompensated Heart Failure from US and UK perspectives [0.03%]
从美国和英国的角度分析急性心力衰竭脱水后GDMT强化治疗的成本效益
Ching-Hsuan Lin,Brandon W Yan,Victoria Yeung et al.
Ching-Hsuan Lin et al.
Pumping up Survival: Strategy of LVAD First in Younger Patients for Net Prolongation of Life [0.03%]
先安装左 ventricle 辅助装置再进行心脏移植可增加年轻患者生存率
Randall C Starling,Michael Z Tong,Edward G Soltesz
Randall C Starling
Iyad N Isseh,Amika McBurnie,Ahmad A Abdul Aziz et al.
Iyad N Isseh et al.
Rationale, Design, and Baseline Characteristics of the Polypill for Heart Failure with Reduced Ejection Fraction (POLY-HF) Trial [0.03%]
用于射血分数降低的心力衰竭患者的单片复方固定剂量药物（POLY-HF试验）的合理性、设计及基线特征
Neil Keshvani,Syed K Rizvi,Fatemeh Khashami et al.
Neil Keshvani et al.
Background: Despite the efficacy of guideline-directed medical therapy (GDMT) for heart failure (HF) with reduced ejection fraction (HFrEF), real-world utilization remains suboptimal. Polypill strategies have been trialed...
Stephanie Golob,Elena Donald,Maria Rosa Costanzo
Stephanie Golob
Jeppe K Petersen,Emil Fosbøl,Lauge Østergaard
Jeppe K Petersen
Bringing it All Back Home [0.03%]
回归家中的一切
Justin M Vader,Robert J Mentz,Anuradha Lala
Justin M Vader
Heart Failure and Atrial Fibrillation: Diagnose One, Anticipate the Other [0.03%]
心力衰竭和房颤：诊断一种，预示另一种
Reniell X Iñiguez,Anna Pfenniger,Kathleen L Grady et al.
Reniell X Iñiguez et al.